Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations

v3.10.0.1
Consolidated Statements Of Operations - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Consolidated Statements Of Operations [Abstract]    
Net revenues $ 15,864,483 $ 13,655,592
Cost of sales 7,081,981 6,636,080
Gross profit 8,782,502 7,019,512
Operating expenses:    
Research and development 10,850,958 3,076,390
Selling, general and administrative 14,817,433 11,501,453
Loss on settlement of accounts receivable 3,986,518  
Business acquisition   935,781
Total operating expenses 29,654,909 15,513,624
Operating loss (20,872,407) (8,494,112)
Non-operating (expense) income:    
Interest expense (2,950,501)  
Change in fair value of derivative liabilities 893,000  
Foreign currency transaction loss (126,928) (61,835)
Other expense, net (15,451) (46,543)
Total non-operating expenses (2,199,880) (108,378)
Loss before income taxes (23,072,287) (8,602,490)
Income tax expense (benefit) 866,102 (1,990,443)
Net loss attributable to common stock holders before preferred stock dividend (23,938,389) (6,612,047)
Preferred stock dividend   1,990,771
Net loss attributable to common stockholders $ (23,938,389) $ (8,602,818)
Net loss per basic and diluted common share outstanding $ (0.44) $ (0.25)
Basic and diluted weighted average common shares outstanding 53,861,981 34,640,308